Clinical Trial

Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to identify potential genetic and other molecular biomarkers of response to radiation therapy in breast cancer that may help to personalize breast cancer radiation treatment in the future.
Trial Details
NCT Number NCT06648148
Lead Sponsor Institute of Oncology Ljubljana
Collaborators: University of Ljubljana, Faculty of Medicine, University Medical Centre Ljubljana
Conditions Breast Cancer, Radiotherapy Side Effect
Enrollment 200 participants
Start Date 2019-11-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-18